Current Concepts on Immunopathology of COVID-19 and Emerging Therapies

被引:2
|
作者
Azimi, Leila [1 ]
Karimi, Abdollah [1 ]
Alebouyeh, Masoud [1 ]
Shirvani, Armin [1 ]
Maham, Saeid [1 ]
Tabatabaei, Sedigheh Rafiei [1 ]
Armin, Shahnaz [1 ]
Fallah, Fatemeh [1 ]
Rajabnejad, Maryam [1 ]
Fahimzad, Seyed Alireza [1 ]
Shirvani, Fariba [1 ]
Ghanaie, Roxana Mansour [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Res Inst Childrens Hlth, Pediat Infect Res Ctr, Tehran, Iran
来源
ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES | 2020年 / 8卷 / 03期
关键词
SARS-CoV-2; COVID-19; Pathogenesis; Vaccine; Treatment; CORONAVIRUS; PNEUMONIA;
D O I
10.5812/pedinfect.104266
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Context: This scoping review tries to synthesize early findings on the immunopathogenicity of SARS-CoV-2 to assess the emerging therapies and vaccines by evaluating their impact based on the mechanism of pathogenicity. Methods: The three databases of PubMed, Scopus, and Google Scholar were searched from January 1, 2020, to March 15, 2020. To extract the results from the studies, the content, thematic analysis method was used. In this method, the topics studied were coded in the articles, and then major topics related to the articles were determined. After identifying major issues, the contents of the articles were reviewed. Results: A total of 2,250 articles were retrieved after deleting duplications, and after reviewing the thematic relevance, 45 of them were selected for the final analysis. Topics studied in the articles were classified into four main areas, including "virus entry inhibition and immuneresponse", "vaccine and treatment targets", "genome structure similarity to other coronaviruses," and "pathogensis". Conclusions: Results of this review showed that we have a long way to develop an effective and safe vaccine due to the structural and behavioral complexities of this virus. In the meantime, the scientific community should use results of megatrials, but until their accomplishing them, we have to use results of systematic reviews of randomized controlled trials.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [21] Hype and Hope of Emerging Therapies to Safeguard against COVID-19 Pandemic
    Shewale, Sunil
    Undale, Vaishali
    Parekh, Sameer
    Pujari, Pramod
    Shelar, Maruti
    Chitlange, Sohan
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (08) : LE1 - LE8
  • [22] Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies
    Premeaux, Thomas A.
    Yeung, Stephen T.
    Bukhari, Zaheer
    Bowler, Scott
    Alpan, Oral
    Gupta, Raavi
    Ndhlovu, Lishomwa C.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Beyond dexamethasone, emerging immuno-thrombotic therapies for COVID-19
    Jensen, Melanie Peta
    George, Marc
    Gilroy, Derek
    Sofat, Reecha
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 845 - 857
  • [24] Current evidence for COVID-19 therapies: a systematic Literature review
    Welte, Tobias
    Ambrose, Lucy J.
    Sibbring, Gillian C.
    Sheikh, Shehla
    Mullerova, Hana
    Sabir, Ian
    EUROPEAN RESPIRATORY REVIEW, 2021, 30 (159):
  • [25] Current regulatory approaches for accessing potential COVID-19 therapies
    Vesa Halimi
    Armond Daci
    Simona Stojanovska
    Irina Panovska-Stavridis
    Milena Stevanovic
    Venko Filipce
    Aleksandra Grozdanova
    Journal of Pharmaceutical Policy and Practice, 13
  • [26] Current Status of COVID-19 Therapies and Drug Repositioning Applications
    Altay, Ozlem
    Mohammadi, Elyas
    Lam, Simon
    Turkez, Hasan
    Boren, Jan
    Nielsen, Jens
    Uhlen, Mathias
    Mardinoglu, Adil
    ISCIENCE, 2020, 23 (07)
  • [27] Pandemic COVID-19: Current status and challenges of antiviral therapies
    Chan, Winglam
    He, Betsy
    Wang, Xiong
    He, Ming-Liang
    GENES & DISEASES, 2020, 7 (04) : 502 - 519
  • [28] Current regulatory approaches for accessing potential COVID-19 therapies
    Halimi, Vesa
    Daci, Armond
    Stojanovska, Simona
    Panovska-Stavridis, Irina
    Stevanovic, Milena
    Filipce, Venko
    Grozdanova, Aleksandra
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
  • [29] COVID-19: immunopathology and its implications for therapy
    Xuetao Cao
    Nature Reviews Immunology, 2020, 20 : 269 - 270
  • [30] A mouse model of COVID-19 associated immunopathology
    Pimenov, Lisabeth
    Gawish, Riem
    Starkl, Philipp
    Hladik, Anastasiya
    Lakovits, Karin
    Repic, Anna Ohradanova
    Oostenbrink, Chris
    Agerer, Benedikt
    Bergthaler, Andreas
    Knapp, Sylvia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 349 - 349